The combination of these characteristics: increased inflammation, obesity and metabolic abnormalities, autonomic dysregulation based on hyperaldosteronism and consequently central MR activation, as well as signs of atypical depression could constitute a specific biological subtype with relevance for a targeted treatment approach. The gene discussed is NR3C2; the disease is depressive symptom measurement.